Concepedia

Wencong Lv

WL

Statistics

Publications

7

Citations

475

H-Index

7

Active since

2018

Affiliations

China Pharmaceutical University(Current)

Nanjing Medical University

University of Michigan

Central South University

State Key Laboratory of Natural Medicine

Wencong Lv is an author at China Pharmaceutical University specializing in medicine, molecular oncology, and oncology.

Publications per year

2018–2021

7

Publications

7

Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis

Rong Fu, Wencong Lv, Ying Xu et al. · Nature Communications · 2020 · 192 citations · Full text

Medicine, Cell Biology, Molecular Biology +16

Inactivation of endothelial ZEB1 impedes tumor progression and sensitizes tumors to conventional therapies

Rong Fu, Yi Li, Nan Jiang et al. · Journal of Clinical Investigation · 2020 · 67 citations · Full text

Medicine, Cancer Biology, Oncology +17

A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours

Rong Fu, Chenfeng Han, Ting Ni et al. · Nature Communications · 2019 · 65 citations · Full text

Medicine, Cancer Biology, Oncology +17

A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer

Hongmei Li, Yan-Ran Bi, Li Yang et al. · Science Advances · 2020 · 53 citations · Full text

Medicine, Oncology, Pharmacology +16

LW106, a novel indoleamine 2,3‐dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma‐immune crosstalk and cancer stem cell enrichment in tumour micro‐environment

Rong Fu, Hongmei Li, Wencong Lv et al. · British Journal of Pharmacology · 2018 · 51 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 7